Humira (Adalimumab): Injection Schedule, Sites, and Tracking

Humira (adalimumab) is a biologic medication that targets tumor necrosis factor alpha (TNF-alpha), a key driver of inflammation in autoimmune diseases. It has been on the market since 2002 and remains one of the most widely prescribed injectable medications in the world, used for conditions ranging from rheumatoid arthritis to Crohn's disease. If you self-inject Humira, keeping a reliable schedule and rotating your injection sites is non-negotiable for treatment success.

Quick Reference -- Humira (Adalimumab)

Detail	Value
Generic name	Adalimumab
Drug class	TNF-alpha inhibitor (biologic)
Route	Subcutaneous (SubQ) only
Delivery	Prefilled pen (Citrate-free) or prefilled syringe
Common dose	40 mg every 2 weeks
Injection sites	Abdomen, front of thigh
Storage	Refrigerate 2-8 degrees C; room temp up to 14 days
Half-life	~14 days
Onset of effect	2-12 weeks depending on condition

What It Is

Adalimumab is a fully human monoclonal antibody. Unlike older biologics that were partly derived from mouse proteins, adalimumab was engineered to be entirely human in origin, which reduces the likelihood of your immune system developing antibodies against the drug itself.

Humira is FDA-approved for a long list of inflammatory conditions:

• Rheumatoid arthritis (RA)
• Crohn's disease (moderate to severe)
• Ulcerative colitis (UC)
• Plaque psoriasis (moderate to severe)
• Psoriatic arthritis
• Ankylosing spondylitis
• Hidradenitis suppurativa
• Juvenile idiopathic arthritis
• Uveitis

The breadth of indications reflects the central role TNF-alpha plays in autoimmune inflammation. When TNF-alpha is overproduced, it drives the tissue damage and symptoms that define these diseases. Blocking it reduces that damage.

Since 2023, several adalimumab biosimilars (Hadlima, Hyrimoz, Cyltezo, and others) have entered the market. These contain the same active molecule with equivalent clinical efficacy. The injection technique, schedule, and tracking recommendations in this guide apply equally to Humira-branded and biosimilar adalimumab.

How It Works

TNF-alpha is a cytokine -- a small signaling protein that your immune system uses to coordinate inflammatory responses. In a healthy immune system, TNF-alpha does useful work: it helps fight infections and promotes tissue repair. In autoimmune diseases, TNF-alpha production goes into overdrive, directing the immune system to attack the body's own tissues.

Adalimumab binds directly to TNF-alpha in the bloodstream and tissues, preventing it from docking with TNF receptors on cell surfaces. No receptor activation means the inflammatory cascade downstream of TNF is interrupted. Joint destruction slows. Intestinal ulceration calms. Skin plaques begin to clear.

This is not a cure. Adalimumab controls the disease by continuously suppressing a specific inflammatory pathway. If you stop treatment, TNF-alpha activity resumes, and symptoms typically return. This is why adherence -- injecting on schedule, every time -- matters as much as the drug itself.

The half-life of adalimumab is approximately 14 days, which aligns with the standard every-other-week dosing interval. Steady-state concentrations are typically reached after about 5 months of consistent dosing. It takes time for the drug to accumulate to its full therapeutic level, which is why clinical improvement may take weeks to months depending on the condition being treated.

Dosing

Dosing varies by condition, and your prescriber will specify the exact regimen. Below are the common patterns:

Rheumatoid arthritis / psoriatic arthritis / ankylosing spondylitis:

• 40 mg SubQ every 2 weeks
• May be used with or without methotrexate

Crohn's disease / ulcerative colitis:

• Loading: 160 mg at week 0 (four 40 mg injections in one day, or two per day over two days)
• Then 80 mg at week 2
• Maintenance: 40 mg every 2 weeks starting at week 4

Plaque psoriasis:

• Loading: 80 mg at week 0
• Then 40 mg at week 1
• Maintenance: 40 mg every 2 weeks

Hidradenitis suppurativa:

• Loading: 160 mg at week 0
• Then 80 mg at week 2
• Maintenance: 40 mg weekly or every 2 weeks

Loading doses are critical. Skipping or mis-timing loading doses delays the time to therapeutic drug levels and can compromise initial response. Track the loading schedule separately from your maintenance schedule if needed.

Injection Sites

Humira is a subcutaneous injection only. Never inject it intramuscularly or intravenously.

Approved injection sites:

• Abdomen -- at least 2 inches (5 cm) from the navel. This is the most commonly used site. Avoid the belt line area.
• Front of thigh -- mid-thigh, avoiding the inner thigh and the area directly above the knee.

Site rotation is essential. Each injection should go into a different spot than the previous one. The easiest system is to alternate between left abdomen, right abdomen, left thigh, and right thigh on a predictable four-site rotation.

Within each general area, vary the exact spot by at least 1 inch from previous injections. This prevents localized reactions and ensures consistent absorption.

Before injecting:

1. Remove the pen or syringe from the refrigerator 15-30 minutes before injection. Injecting cold medication hurts more.
2. Choose a site that is not bruised, red, tender, or hard.
3. Clean the site with an alcohol swab and let it dry completely.
4. If using the pen, press firmly against the skin and press the button. Hold for 10 seconds (or until the window shows completion). If using the syringe, pinch the skin and inject slowly.
5. Do not rub the site after injection. Light pressure with a cotton ball is fine.

Injection site reactions -- redness, swelling, itching, or mild pain at the site -- are the most common side effect of Humira. They typically resolve within 3-5 days and tend to decrease over time as your body adjusts.

Side Effects

Humira suppresses part of the immune system by design. That therapeutic mechanism also produces its most significant risk: increased susceptibility to infections.

Common side effects:

• Injection site reactions (redness, pain, swelling, itching)
• Upper respiratory infections (cold, sinus infection)
• Headache
• Rash
• Nausea

Serious side effects (require immediate medical attention):

• Serious infections -- fever, chills, persistent cough, flu-like symptoms, unusual fatigue. TNF inhibitors increase the risk of bacterial, viral, and fungal infections, including tuberculosis reactivation.
• Signs of blood disorders -- persistent bruising, bleeding, pallor
• Liver toxicity -- jaundice (yellowing of skin/eyes), dark urine, severe abdominal pain
• New or worsening heart failure symptoms -- shortness of breath, leg swelling
• Neurological symptoms -- numbness, tingling, vision changes
• Allergic reaction -- difficulty breathing, facial swelling, hives

Before starting Humira, your prescriber will order a tuberculosis (TB) test and a hepatitis B test. Active TB or untreated hepatitis B are contraindications.

Report any infection symptoms promptly. On a TNF inhibitor, even a minor-seeming infection can escalate quickly. Your prescriber needs to know about fevers, persistent coughs, or unusual fatigue -- do not wait for your next appointment.

What to Monitor

Effective Humira treatment requires ongoing monitoring beyond the injection itself.

Clinical monitoring:

Self-monitoring (track these regularly):

• Symptom severity -- joint pain, stiffness, bowel symptoms, skin clearance (depending on your condition)
• Injection site reactions -- location, severity, how long they last
• Infection symptoms -- any fever, cough, sore throat, or unusual fatigue
• Medication supply -- Humira requires a specialty pharmacy; refill lead times can be 1-2 weeks
• Insurance / copay status -- prior authorizations typically renew annually

If your symptoms return despite consistent dosing, your prescriber may check adalimumab drug levels and anti-drug antibodies. Some patients develop antibodies to adalimumab over time, which reduces its effectiveness. This is more common in patients not taking concurrent methotrexate.

Tracking Your Humira Injections

Every-other-week dosing sounds simple until you miss one and cannot remember whether you are due this week or next. A tracking system eliminates the guesswork.

What to log for every injection:

• Date and time of injection
• Dose (40 mg standard; note if loading dose)
• Injection site -- specific location and side (e.g., left abdomen, right thigh)
• Pen or syringe (and lot number if you want to be thorough)
• Injection site reaction -- severity, duration
• Room-temperature time -- if you removed the pen from the fridge early, note how long it was at room temp (14-day limit applies)
• Next injection date

Why tracking matters more for biologics:

Biologics like Humira are expensive, require cold-chain storage, and work on an accumulation model -- the drug builds to steady-state levels over weeks. A missed dose does not just affect that one day; it drops your drug level below the therapeutic threshold and can trigger an antibody response that permanently reduces the drug's effectiveness. The stakes for adherence are higher than with most medications.

Tracking your injection dates, site rotation, and symptom trends also gives your rheumatologist, gastroenterologist, or dermatologist the data they need to make confident decisions about whether to continue, adjust, or switch therapy.

For broader guidance on choosing a tracking tool, see our best medication tracker app guide.

Frequently Asked Questions

How often do you inject Humira?

The most common maintenance schedule is one subcutaneous injection every two weeks. Some conditions require weekly dosing, and initial loading doses may be given on a different schedule. Your prescriber determines the frequency based on your diagnosis and response.

Where do you inject Humira?

Humira is injected subcutaneously into the front of the thigh or the abdomen (at least 2 inches from the navel). Rotate between sites with each injection, and avoid areas that are bruised, tender, red, or hard.

What happens if I miss a Humira dose?

If you miss a dose, inject it as soon as you remember, then resume your regular schedule. If your next dose is due soon, contact your prescriber for guidance rather than doubling up. Tracking your injection dates prevents this scenario.

Does Humira need to be refrigerated?

Yes. Store Humira in the refrigerator at 2-8 degrees C (36-46 degrees F). Do not freeze. A single pen or syringe can be stored at room temperature (up to 25 degrees C / 77 degrees F) for a maximum of 14 days, after which it must be discarded if not used.

Can I travel with Humira?

Yes. Use an insulated travel case with ice packs to keep Humira within the 2-8 degrees C range. TSA allows medically necessary liquids and syringes through security. Carry your prescription or a doctor's letter as documentation.

Sources

1. Humira (adalimumab) - FDA Prescribing Information -- U.S. Food and Drug Administration
2. Adalimumab: A Review of Its Use in Rheumatoid Arthritis -- Drugs
3. Self-Injection Education for Patients with Rheumatoid Arthritis -- Arthritis Foundation
4. Adalimumab in Crohn's Disease: CLASSIC-I Trial -- Gastroenterology
5. Injection Site Reactions and Injection Technique -- National Library of Medicine

Done Dose handles the parts of biologic therapy that memory alone cannot -- precise every-other-week scheduling, injection site rotation tracking, symptom logging, and refill reminders timed to specialty pharmacy lead times. One tap after each injection keeps your adherence record clean and gives your specialist real data at every visit. Start tracking your Humira injections with Done Dose.